Search
Returning search results with filters:
Remove filter for
Audience: Health professionals
Remove filter for
Category: Drugs
Remove filter for
Type: Information update
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
Displaying 1 - 10 of 10 items.
LEO Pharma Inc. is withdrawing the drug Picato (Ingenol mebutate), used to treat skin lesions, due to the potential increased risk of skin cancer
AlertInformation update | 2020-10-27
Information Update - Use of the drug Picato may increase the risk of skin cancer
AlertInformation update | 2020-07-02
Chloroquine and hydroxychloroquine can have serious side effects. These drugs should be used only under the supervision of a physician.
AlertInformation update | 2020-04-25
No scientific evidence that ibuprofen worsens COVID-19 symptoms
AlertInformation update | 2020-03-20
Health Canada evaluating NDMA in metformin drugs
AlertInformation update | 2019-12-05
Health Canada advises Canadians to exercise caution when taking gabapentin or pregabalin with opioids
AlertInformation update | 2019-09-17
Substance use during summer events and festivals
AlertInformation update | 2019-06-20
Health Canada is advising Canadians about the potential health risks associated with unauthorized cell therapy treatments such as stem cell therapy
AlertInformation update | 2019-05-15
Cannabis and Alcohol Use During the Holidays
AlertInformation update | 2018-12-17
New safety information for women using dolutegravir, a medication used to treat HIV infection
AlertInformation update | 2018-06-07